Expert: Implementing CED Differently Could Help Boost Innovation

By Maaisha Osman / October 22, 2024 at 1:21 PM

A top industry expert tells Inside Health Policy CMS’ coverage with evidence development (CED) process can play a positive role in the drug development industry by serving as a tool to demonstrate the value for therapies and products and ultimately boost innovation.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.

FEATURES

NEWSLETTERS

ABOUT US

Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.

SITE LICENSES

Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.

STAY CONNECTED

Expert: Implementing CED Differently Could Help Boost Innovation

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.